Distinct telomore length regulation in premalignant cervical and endometrial lesion: Implications for the roles of telomeres in uterine carcinogenesis

Journal of Pathology

Volumn 210, Issue 2, 2006, Pages 214-223

  Maida, Y ^a   Kyo, S ^a   Forsyth, N R ^b   Takakura, M ^a   Sakaguchi, J ^a   Mizumoto, Y ^a   Hashimoto, M ^a   Nakamura, M ^a   Nakao, S ^a   Inoue, M ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cervical cancer; CIN; Endometrial cancer; Endometrial hyperplasia; Telomerase; Telomere

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL HETEROGENEITY; CELL LABELING; CHROMOSOMAL INSTABILITY; CHROMOSOME ARM; CHROMOSOME LOSS; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC GAIN; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS EPITHELIUM; TELOMERE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL TRANSFORMATION; CHROMOSOME 17; DISEASE COURSE; ENDOMETRIUM TUMOR; ENZYME IMMUNOASSAY; GENETICS; IMAGE PROCESSING; METHODOLOGY; PATHOLOGY; UTERINE CERVIX TUMOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 17; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICE, INBRED BALB C; PRECANCEROUS CONDITIONS; TELOMERE; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 33749080758     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2038     Document Type: Article

References (34)

1. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-374.
2. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-649.
3. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-573.
4. Blackburn EH. Switching and signaling at the telomere. Cell 2001;106:661-673.
5. Blackburn EH. Telomere states and cell fates. Nature 2000;408:53-56.
6. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, Hoglund M, et al. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A 2001;98:12683-12688.
7. Hande MP, Samper E, Lansdorp P, Blasco MA. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 1999;144:589-601.
8. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science 2002;297:565-569.
9. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999;96:701-712.
10. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999;97:527-538.
11. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000;406:641-645.
12. Meeker AK, Gage WR, Hicks JL, Simon I, Coffman JR, Platz EA, et al. Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. Am J Pathol 2002; 160:1259-1268.
13. Kyo S, Masutomi K, Maida M, Kanaya T, Yatabe N, Nakamura M, et al. Significance of immunological detection of hTERT: re-evaluation of expression and localization of hTERT. Am J Pathol 2003;163:859-867.
14. Martens UM, Zijlmans JM, Poon SS, Dragowska W, Yui J, Chavez EA, et al. Short telomeres on human chromosome 17p. Nature Genet 1998;18:76-80.
15. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer 1999;80:2008-2019.
16. Sirchia SM, Sironi E, Grati FR, Serafini P, Garagiola I, Rossella F, et al. Losses of heterozygosity in endometrial adenocarcinomas: positive correlations with histopathological parameters. Cancer Genet Cytogenet 2000;121:156-162.
17. Zijlmans JM, Martens UM, Poon SS, Raap AK, Tanke HJ, Ward RK, et al. Telomeres in the mouse have large interchromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci U S A 1997;94:7423-7428.
18. Kyo S, Takakura M, Tanaka M, Kanaya T, Inoue M. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer 1998;79:66-70.
19. Duensing S, Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 2002;62:7075-7082.
20. Plug-DeMaggio AW, Sundsvold T, Wurscher MA, Koop JI, Klingelhutz AJ, McDougall JK. Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6. Oncogene 2004;23:3561-3571.
21. Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 2003;17:88-100.
22. Zhang A, Wang J, Zheng B, Fang X, Angstrom T, Liu C, et al. Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene 2004;23:7441-7447.
23. Meeker AK, Hicks JL, Gabrielson E, Strauss WM, De Matzo AM, Argani P. Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol 2004;164:925-935.
24. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, et al. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 2004;10:3317-3326.
25. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nature Genet 2002;32:280-284.
26. van Heek NT, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, et al. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002;161:1541-1547.
27. Vukovic B, Park PC, Al-Maghrabi J, Beheshti B, Sweet J, Evans A, et al. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene 2003;22:1978-1987.
28. Meeker AK, Hicks JL, Platz EA, March GE, Bennett CJ, Delannoy MJ, et al. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res 2002;62:6405-6409.
29. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res 1997;57:610-614.
30. Burks RT, Kessis TD, Cho KR, Hedrick L. Microsatellite instability in endometrial carcinoma. Oncogene 1994;9:1163-1166.
31. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 1998;17:2413-2417.
32. Simpkins SB, Bocker T, Swisher EM, Mutch DG, Gersell DJ, Kovatich AJ, et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum. Mol. Genet. 1999;8:661-666.
33. Kanaya T, Kyo S, Maida Y, Yatabe N, Tanaka M, Nakamura M, et al. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Oncogene 2003;22:2352-2360.
34. Kanaya T, Kyo S, Sakaguchi J, Maida Y, Nakamura M, Takakura M, et al. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population. Am J Clin Pathol 2005;124:89-96.